Jason K.
About Jason K.
Jason K. is an Associate Director and Principal Product Quality Lead at Bristol Myers Squibb, specializing in cell therapy products in Seattle, Washington.
Company
Jason K. is currently working at Bristol Myers Squibb, a leading global biopharmaceutical company. He is based in Seattle, Washington, United States. Bristol Myers Squibb is known for its innovative approach to treating serious diseases, focusing on areas such as oncology, hematology, immunology, and cardiovascular disease.
Title
Jason K. holds the position of Associate Director, Principal Product Quality Lead at Bristol Myers Squibb. In this role, he is primarily responsible for leading the lifecycle management of cell therapy products, specifically focusing on viral vectors. His responsibilities include overseeing processes, specifications, and testing of cell therapy products from development through commercialization and approval.
Education and Expertise
Jason K. has a robust educational background with degrees from two prestigious universities. He earned his Bachelor’s Degree from Michigan State University and later obtained a Master’s Degree from The Johns Hopkins University. His academic credentials have provided a strong foundation for his career in the biopharmaceutical industry, specifically in the realm of cell therapy product quality management.
Background
Jason K. has extensive experience in the biopharmaceutical industry, particularly in managing the lifecycle of cell therapy products, including viral vectors. Since September 2020, he has been leading the lifecycle management of cell therapy product viral vectors at Bristol Myers Squibb. His role encompasses a focus on maintaining the highest quality standards for cell therapy products throughout their development and commercial lifecycle.
Achievements
Since taking on his current role at Bristol Myers Squibb, Jason K. has been instrumental in overseeing the quality aspects of cell therapy products in the Greater Seattle Area. His work ensures that these products meet rigorous quality standards from development through commercialization and regulatory approval. His leadership in the lifecycle management of cell therapy products has been a critical component of Bristol Myers Squibb’s efforts in the field of cell therapy.